Status:
NOT_YET_RECRUITING
An Integrated Care Platform Based on the Monitoring of Older Individual Intrinsic Capacity for Inclusive Health (CAREUP)
Lead Sponsor:
Istituto Nazionale di Ricovero e Cura per Anziani
Collaborating Sponsors:
European Union
Conditions:
Old Age
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The objective of this study is to assess the usability and acceptance of the CAREUP solution in improving the quality of life at home of the older adults. The CAREUP solution is a platform that collec...
Detailed Description
The objective of this study is to assess the usability and acceptance of the CAREUP solution at home in primary (older adults), secondary (informal caregivers) and tertiary (doctors and geriatrics) en...
Eligibility Criteria
Inclusion
- Live independently in their home in rural or urban areas;
- In good physical and cognitive status;
- Able to stand and walk unaided;
- Availability to sign the Informed Consent;
- Ability to use smartphones/tablets independently.
Exclusion
- Use of active implant or not-implant medical devices;
- Allergy to nickel components;
- Lack of written informed consent;
- Acute or untreated medical problems such as history of syncopal episodes, epilepsy and vertigo not controlled pharmacologically; serious dysfunction of the autonomic system; severe behavioural syndromes not compensated by drugs; concurrent neurological diseases; severe systemic diseases with life expectancy \< 1 year;
- A myocardial infarction or stroke within 6 months;
- Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;
- Uncontrolled hypertension;
- Pacemaker or implantable cardioverter defibrillator;
- Diagnosis of mild and or/advanced Parkinson's disease or other neuromuscular disorder;
- Diagnosis of mild and/or advance cognitive impairments
- Metastatic cancer or immunosuppressive therapy;
- Significant visual or hearing impairment
Key Trial Info
Start Date :
April 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 14 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05963399
Start Date
April 30 2024
End Date
December 14 2024
Last Update
March 5 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
EURAG Austria
Vienna, Austria
2
IRCCS INRCA Hospital
Ancona, Italy, 60127
3
Ana Aslan International Foundation
Bucharest, Romania